Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 23, 2011 - Issue 6
202
Views
15
CrossRef citations to date
0
Altmetric
Research Article

The role of iron in Libby amphibole-induced acute lung injury and inflammation

, , , , , & show all
Pages 313-323 | Received 09 Feb 2011, Accepted 03 Mar 2011, Published online: 24 May 2011

References

  • Blum A. 2009. Heart failure–new insights. Isr Med Assoc J 11:105–111.
  • Cheng N, Shi X, Ye J, Castranova V, Chen F, Leonard SS, Vallyathan V, Rojanasakul Y. 1999. Role of transcription factor NF-κB in asbestos-induced TNFα response from macrophages. Exp Mol Pathol 66:201–210.
  • Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677.
  • Duncan KE, Ghio AJ, Dailey LA, Bern AM, Gibbs-Flournoy EA, Padilla-Carlin DJ, Roggli VL, Devlin RB. 2010. Effect of size fractionation on the toxicity of amosite and Libby amphibole asbestos. Toxicol Sci 118:420–434.
  • Eborn SK, Aust AE. 1995. Effect of iron acquisition on induction of DNA single-strand breaks by erionite, a carcinogenic mineral fiber. Arch Biochem Biophys 316:507–514.
  • Fang R, Aust AE. 1997. Induction of ferritin synthesis in human lung epithelial cells treated with crocidolite asbestos. Arch Biochem Biophys 340:369–375.
  • Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW. 2010. Combined iron chelation therapy. Ann N Y Acad Sci 1202:79–86.
  • Gazzano E, Turci F, Foresti E, Putzu MG, Aldieri E, Silvagno F, Lesci IG, Tomatis M, Riganti C, Romano C, Fubini B, Roveri N, Ghigo D. 2007. Iron-loaded synthetic chrysotile: A new model solid for studying the role of iron in asbestos toxicity. Chem Res Toxicol 20:380–387.
  • Ghiazza M, Scherbart AM, Fenoglio I, Grendene F, Turci F, Martra G, Albrecht C, Schins RP, Fubini B. 2011. Surface iron inhibits quartz-induced cytotoxic and inflammatory responses in alveolar macrophages. Chem Res Toxicol 24:99–110.
  • Ghio AJ, Churg A, Roggli VL. 2004. Ferruginous bodies: implications in the mechanism of fiber and particle toxicity. Toxicol Pathol 32:643–649.
  • Ghio AJ, Funkhouser W, Pugh CB, Winters S, Stonehuerner JG, Mahar AM, Roggli VL. 2006. Pulmonary fibrosis and ferruginous bodies associated with exposure to synthetic fibers. Toxicol Pathol 34:723–729.
  • Ghio AJ, Stonehuerner J, Richards J, Devlin RB. 2008. Iron homeostasis in the lung following asbestos exposure. Antioxid Redox Signal 10:371–377.
  • Ghio AJ, Zhang J, Piantadosi CA. 1992. Generation of hydroxyl radical by crocidolite asbestos is proportional to surface [Fe3+]. Arch Biochem Biophys 298:646–650.
  • Gibbs AR, Gardner MJ, Pooley FD, Griffiths DM, Blight B, Wagner JC. 1994. Fiber levels and disease in workers from a factory predominantly using amosite. Environ Health Perspect 102 Suppl 5:261–263.
  • Gilmour PS, Brown DM, Beswick PH, MacNee W, Rahman I, Donaldson K. 1997. Free radical activity of industrial fibers: role of iron in oxidative stress and activation of transcription factors. Environ Health Perspect 105 Suppl 5:1313–1317.
  • Governa M, Amati M, Fontana S, Visona I, Botta GC, Mollo F, Bellis D, Bo P. 1999. Role of iron in asbestos-body-induced oxidant radical generation. J Toxicol Environ Health Part A 58:279–287.
  • Gozzelino R, Jeney V, Soares MP. 2010. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50:323–354.
  • Haegens A, Barrett TF, Gell J, Shukla A, Macpherson M, Vacek P, Poynter ME, Butnor KJ, Janssen-Heininger YM, Steele C, Mossman BT. 2007. Airway epithelial NF-κB activation modulates asbestos-induced inflammation and mucin production in vivo. J Immunol 178:1800–1808.
  • Haegens A, van der Vliet A, Butnor KJ, Heintz N, Taatjes D, Hemenway D, Vacek P, Freeman BA, Hazen SL, Brennan ML, Mossman BT. 2005. Asbestos-induced lung inflammation and epithelial cell proliferation are altered in myeloperoxidase-null mice. Cancer Res 65:9670–9677.
  • Hardy JA, Aust AE. 1995. The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16:319–325.
  • Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Beuschel SL, Butnor KJ, Testa JR, Pass HI, Carbone M, Steele C, Mossman BT. 2010. Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Ann N Y Acad Sci 1203:7–14.
  • Hodgson JT, Darnton A. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 44:565–601.
  • Kamp DW, Israbian VA, Preusen SE, Zhang CX, Weitzman SA. 1995a. Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: Role of iron-catalyzed free radicals. Am J Physiol 268:L471–L480.
  • Kamp DW, Israbian VA, Yeldandi AV, Panos RJ, Graceffa P, Weitzman SA. 1995b. Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos. Toxicol Pathol 23:689–695.
  • Kamp DW, Weitzman SA. 1999. The molecular basis of asbestos induced lung injury. Thorax 54:638–652.
  • Koorts AM, Viljoen M. 2007. Ferritin and ferritin isoforms I: Structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem 113:30–54.
  • Kruszewski M. 2004. The role of labile iron pool in cardiovascular diseases. Acta Biochim Pol 51:471–480.
  • Lowers HA, Bern AM. 2009. Particle Size Characterization of Water-Elutriated Libby Amphibole 2000 and RTI International Amosite. USGS Open File Report 2009–1242.
  • Lund LG, Williams MG, Dodson RF, Aust AE. 1994. Iron associated with asbestos bodies is responsible for the formation of single strand breaks in phi X174 RFI DNA. Occup Environ Med 51:200–204.
  • McDonald JC. 1998. Mineral fibre persistence and carcinogenicity. Ind Health 36:372–375.
  • Meeker GP, Bern AM, Brownfield IK, Lowers HA, Sutley SJ, Hoefen TM, Vance JS. 2003. The composition and morphology of amphiboles from the Rainy Creek Complex, near Libby, Montana. American Mineralogist 88:1955–1969.
  • Muravov OI, Kaye WE, Lewin M, Berkowitz Z, Lybarger JA, Campolucci SS, Parker JE. 2005. The usefulness of computed tomography in detecting asbestos-related pleural abnormalities in people who had indeterminate chest radiographs: The Libby, MT, experience. Int J Hyg Environ Health 208:87–99.
  • Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, Weis C, Spence M, Black B, Kapil V. 2003. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ Health Perspect 111:1753–1759.
  • Pooley FD. 1972. Asbestos bodies, their formation, composition and character. Environ Res 5:363–379.
  • Poser I, Rahman Q, Lohani M, Yadav S, Becker HH, Weiss DG, Schiffmann D, Dopp E. 2004. Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor. Mutat Res 559:19–27.
  • Roggli VL. 1990. Human disease consequences of fiber exposures: A review of human lung pathology and fiber burden data. Environ Health Perspect 88:295–303.
  • Sanchez VC, Pietruska JR, Miselis NR, Hurt RH, Kane AB. 2009. Biopersistence and potential adverse health impacts of fibrous nanomaterials: What have we learned from asbestos? Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:511–529.
  • Shannahan JH, Schladweiler MC, Richards JH, Ledbetter AD, Ghio AJ, Kodavanti UP. 2010. Pulmonary oxidative stress, inflammation, and dysregulated iron homeostasis in rat models of cardiovascular disease. J Toxicol Environ Health Part A 73:641–656.
  • Shannahan JH, Schladweiler MC, Padilla-Carlin DJ, Nyska A, Richards JH, Ghio AJ, Gavett SH, Kodavanti UP. 2011. The role of cardiovascular disease-associated iron overload in Libby amphibole-induced pulmonary injury and inflammation. Inhal Toxicol (In Press).
  • Shen Z, Bosbach D, Hochella MF Jr, Bish DL, Williams MG Jr, Dodson RF, Aust AE. 2000. Using in vitro iron deposition on asbestos to model asbestos bodies formed in human lung. Chem Res Toxicol 13:913–921.
  • Sullivan PA. 2007. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: Update of a cohort mortality study. Environ Health Perspect 115:579–585.
  • Treffry A, Harrison PM, Cleton MI, de Bruijn WC, Mann S. 1987. A note on the composition and properties of ferritin iron cores. J Inorg Biochem 31:1–6.
  • U.S. EPA. 2007. Method 200.7 Revision 4.4: Determination of metals and trace elements in water and wastes by inductively coupled plasma -atomic emission spectrometry. In: Methods for the determination of metals in environmental samples, supplement I. EPA/600/R-94/111. Available: http://www.epa.gov/waterscience/methods/method/files/200_7.pdf
  • U.S. EPA. 2010. Particle size distribution data for Libby amphibole structures observed in air at the Libby asbestos Superfund site. Superfund Records Center, U.S. EPA Region 8, Denver, Co.
  • Vinikoor LC, Larson TC, Bateson TF, Birnbaum L. 2010. Exposure to asbestos-containing vermiculite ore and respiratory symptoms among individuals who were children while the mine was active in Libby, Montana. Environ Health Perspect 118:1033–1028.
  • Wallenborn JG, Kovalcik KD, McGee JK, Landis MS, Kodavanti UP. 2009. Systemic translocation of (70)zinc: Kinetics following intratracheal instillation in rats. Toxicol Appl Pharmacol 234:25–32.
  • Wang X, Samet JM, Ghio AJ. 2006a. Asbestos-induced activation of cell signaling pathways in human bronchial epithelial cells. Exp Lung Res 32:229–243.
  • Wang X, Wu Y, Stonehuerner JG, Dailey LA, Richards JD, Jaspers I, Piantadosi CA, Ghio AJ. 2006b. Oxidant generation promotes iron sequestration in BEAS-2B cells exposed to asbestos. Am J Respir Cell Mol Biol 34:286–292.
  • Webber JS, Blake DJ, Ward TJ, Pfau JC. 2008. Separation and characterization of respirable amphibole fibers from Libby, Montana. Inhal Toxicol 20:733–740.
  • Weinberg ED. 2009. Iron availability and infection. Biochim Biophys Acta 1790:600–605.
  • Whitehouse AC, Black CB, Heppe MS, Ruckdeschel J, Levin SM. 2008. Environmental exposure to Libby Asbestos and mesotheliomas. Am J Ind Med 51:877–880.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.